A Novel Set of WNT Pathway Effectors as a Predictive Marker of Uterine Corpus Endometrial Carcinoma–Study Based on Weighted Co-Expression Matrices

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00360
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Study of Her2/Neu Expression in 100 Cases of Uterine and Cervical Carcinoma as a Prognostic Marker

Annals of Pathology and Laboratory Medicine
2018English

P7: Co-Expression of Activating and Inhibitory Receptors on Uterine Endometrial NK Cells

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2018English

ERCC1 Expression as a Predictive Marker of Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Concurrent Chemoradiation

British Journal of Cancer
Cancer ResearchOncology
2008English

Identification of Matrix Metalloproteinase 11 as a Predictive Tumor Marker in Serum Based on Gene Expression Profiling

Clinical Cancer Research
Cancer ResearchOncology
2008English

A Study of Cis-Diamminedichloroplatinum(II) Suppositories for the Treatment of Rabbit Uterine Endometrial Carcinoma.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1993English

Serum MMP-2 as a Potential Predictive Marker for Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

Expression of -Catenin, a Key Mediator of the WNT Signaling Pathway, in Basal Cell Carcinoma

Archives of Dermatology
2000English

BCL-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated With Taxane-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Correction: A Novel WNT Regulatory Axis in Endometrioid Endometrial Cancer

Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy